Life Science Reit reduces dividend payment due to economic challenges delaying rollout

Life Science Reit (LABS) has announced that it will halve its dividends for 2023, reducing the second payment of the year from 3p to 1p per share. Despite reporting good progress in its annual results for the year ending on 31 December, the £284m specialist property fund faced challenges such as economic uncertainty, occupiers delaying rental decisions, and high interest rates.

In order to ensure its earnings were covered and could sustainably grow from this level, LABS had to make a difficult decision to rebase the dividend. By cutting dividends, the company aims to have additional financial flexibility to effectively deliver on its strategy.

By Riley Johnson

As a content writer at, I dive into the depths of information to craft compelling stories that captivate and inform readers. With a keen eye for detail and a passion for storytelling, I strive to create engaging content that resonates with our audience. Whether it's breaking news, in-depth features, or thought-provoking opinion pieces, I am dedicated to delivering high-quality, informative content that keeps readers coming back for more. My goal is to bring a fresh perspective to every article I write and to make a meaningful impact through the power of words.

Leave a Reply